| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |